103 related articles for article (PubMed ID: 17575123)
1. Initial analyses of colon cancer-specific antigen (CCSA)-3 and CCSA-4 as colorectal cancer-associated serum markers.
Leman ES; Schoen RE; Weissfeld JL; Cannon GW; Sokoll LJ; Chan DW; Getzenberg RH
Cancer Res; 2007 Jun; 67(12):5600-5. PubMed ID: 17575123
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of colon cancer-specific antigen 2 as a potential serum marker for colorectal cancer.
Leman ES; Schoen RE; Magheli A; Sokoll LJ; Chan DW; Getzenberg RH
Clin Cancer Res; 2008 Mar; 14(5):1349-54. PubMed ID: 18316554
[TBL] [Abstract][Full Text] [Related]
3. The use of a colon cancer associated nuclear antigen CCSA-2 for the blood based detection of colon cancer.
Walgenbach-Brunagel G; Burger B; Leman ES; Walgenbach KJ; Tolba R; Heukamp L; Hirner A; Getzenberg RH
J Cell Biochem; 2008 May; 104(1):286-94. PubMed ID: 18044711
[TBL] [Abstract][Full Text] [Related]
4. The evaluation of diagnostic value of the tumor markers: CCSA-2 and CEA in colorectal cancer.
Knychalski B; Lukieńczuk T
Pol Przegl Chir; 2012 Feb; 84(2):86-92. PubMed ID: 22487741
[TBL] [Abstract][Full Text] [Related]
5. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
[TBL] [Abstract][Full Text] [Related]
6. Serum insulin levels and the prevalence of adenomatous and hyperplastic polyps in the proximal colon.
Yoshida I; Suzuki A; Vallée M; Matano Y; Masunaga T; Zenda T; Shinozaki K; Okada T
Clin Gastroenterol Hepatol; 2006 Oct; 4(10):1225-31. PubMed ID: 16979948
[TBL] [Abstract][Full Text] [Related]
7. Predictors of advanced proximal neoplasia in persons with abnormal screening flexible sigmoidoscopy.
Pinsky PF; Schoen RE; Weissfeld JL; Bresalier RS; Hayes RB; Gohagan JK
Clin Gastroenterol Hepatol; 2003 Mar; 1(2):103-10. PubMed ID: 15017502
[TBL] [Abstract][Full Text] [Related]
8. Quantitative immunochemical fecal occult blood testing for colorectal adenoma detection: evaluation in the target population of screening and comparison with qualitative tests.
Haug U; Hundt S; Brenner H
Am J Gastroenterol; 2010 Mar; 105(3):682-90. PubMed ID: 19953091
[TBL] [Abstract][Full Text] [Related]
9. The importance of monitoring colorectal adenomas by tumor markers (ROC analysis).
Stajic S; Novaković R; Kostić N; Josifovski J; Simić P; Katić V; Kovijanić M
Med Pregl; 1993; 46 Suppl 1():69-71. PubMed ID: 8569613
[TBL] [Abstract][Full Text] [Related]
10. Serum p53 antibody as tumor marker for follow-up of colorectal cancer after curative resection.
Tang R; Yeh CY; Wang JY; Changchien CR; Chen JS; Hsieh LL
Ann Surg Oncol; 2009 Sep; 16(9):2516-23. PubMed ID: 19565285
[TBL] [Abstract][Full Text] [Related]
11. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.
Lieberman DA; Weiss DG;
N Engl J Med; 2001 Aug; 345(8):555-60. PubMed ID: 11529208
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic value of G-CSF measurement in the sera of colorectal cancer and adenoma patients.
Mroczko B; Groblewska M; Wereszczynska-Siemiatkowska U; Kedra B; Konopko M; Szmitkowski M
Clin Chim Acta; 2006 Sep; 371(1-2):143-7. PubMed ID: 16603145
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of autofluorescence colonoscopy for the detection and diagnosis of colonic polyps.
McCallum AL; Jenkins JT; Gillen D; Molloy RG
Gastrointest Endosc; 2008 Aug; 68(2):283-90. PubMed ID: 18329642
[TBL] [Abstract][Full Text] [Related]
14. Classification criteria for advanced adenomas of the colon by using probe-based confocal laser endomicroscopy: a preliminary study.
Gómez V; Shahid MW; Krishna M; Heckman MG; Crook JE; Wallace MB
Dis Colon Rectum; 2013 Aug; 56(8):967-73. PubMed ID: 23838865
[TBL] [Abstract][Full Text] [Related]
15. EPCA-2: a highly specific serum marker for prostate cancer.
Leman ES; Cannon GW; Trock BJ; Sokoll LJ; Chan DW; Mangold L; Partin AW; Getzenberg RH
Urology; 2007 Apr; 69(4):714-20. PubMed ID: 17445657
[TBL] [Abstract][Full Text] [Related]
16. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].
Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H
Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334
[TBL] [Abstract][Full Text] [Related]
17. Galanin is up-regulated in colon adenocarcinoma.
Kim KY; Kee MK; Chong SA; Nam MJ
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2373-8. PubMed ID: 18006926
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for advanced colorectal adenomas: a pooled analysis.
Terry MB; Neugut AI; Bostick RM; Sandler RS; Haile RW; Jacobson JS; Fenoglio-Preiser CM; Potter JD
Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):622-9. PubMed ID: 12101109
[TBL] [Abstract][Full Text] [Related]
19. Using a combination of cytochrome P450 1B1 and beta-catenin for early diagnosis and prevention of colorectal cancer.
Chang H; Su JM; Huang CC; Liu LC; Tsai CH; Chou MC; Lin P
Cancer Detect Prev; 2005; 29(6):562-9. PubMed ID: 16289386
[TBL] [Abstract][Full Text] [Related]
20. Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer.
Fedarko NS; Jain A; Karadag A; Van Eman MR; Fisher LW
Clin Cancer Res; 2001 Dec; 7(12):4060-6. PubMed ID: 11751502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
